Top Markets
Coin of the day
ProUroCare Medical Inc. ProUroCare Medical Inc.

ProUroCare Medical Inc.

PUMD
Pozycja w akcjach #42361
ProUroCare Medical Inc. is dedicated to developing advanced products for the... ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Cena akcji
$0.0001
Ostatnia synchronizacja: 2026-08-11
Kapitalizacja rynkowa
$1.86K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-50.00%
Kraj
US
Handel ProUroCare Medical Inc. (PUMD)

Kategoria

EPS dla ProUroCare Medical Inc. (PUMD)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy ProUroCare Medical Inc., obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla ProUroCare Medical Inc. od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów